These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 9725211

  • 21. Induction of costimulation of human CD4 T cells by tumor necrosis factor-related apoptosis-inducing ligand: possible role in T cell activation in systemic lupus erythematosus.
    Tsai HF, Lai JJ, Chou AH, Wang TF, Wu CS, Hsu PN.
    Arthritis Rheum; 2004 Feb; 50(2):629-39. PubMed ID: 14872508
    [Abstract] [Full Text] [Related]

  • 22. Immunologically-mediated tumour cell apoptosis: the role of TRAIL in T cell and cytokine-mediated responses to melanoma.
    Nguyen T, Thomas W, Zhang XD, Gray C, Hersey P.
    Forum (Genova); 2000 Feb; 10(3):243-52. PubMed ID: 11007932
    [Abstract] [Full Text] [Related]

  • 23. HIV-1 Tat protects CD4+ Jurkat T lymphoblastoid cells from apoptosis mediated by TNF-related apoptosis-inducing ligand.
    Gibellini D, Re MC, Ponti C, Maldini C, Celeghini C, Cappellini A, La Placa M, Zauli G.
    Cell Immunol; 2001 Feb 01; 207(2):89-99. PubMed ID: 11243698
    [Abstract] [Full Text] [Related]

  • 24. Are blockers of gp120/CD4 interaction effective inhibitors of HIV-1 immunopathogenesis?
    Herbeuval JP, Shearer GM.
    AIDS Rev; 2006 Feb 01; 8(1):3-8. PubMed ID: 16736946
    [Abstract] [Full Text] [Related]

  • 25. Distinct function of monoclonal antibody to TRAIL-R2 as potentiator or inhibitor of the ligand TRAIL-induced apoptosis.
    Mori E, Thomas M, Motoki K, Kataika S.
    FEBS Lett; 2005 Oct 10; 579(24):5379-84. PubMed ID: 16199041
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
    Suliman A, Lam A, Datta R, Srivastava RK.
    Oncogene; 2001 Apr 19; 20(17):2122-33. PubMed ID: 11360196
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma.
    Griffith TS, Fialkov JM, Scott DL, Azuhata T, Williams RD, Wall NR, Altieri DC, Sandler AD.
    Cancer Res; 2002 Jun 01; 62(11):3093-9. PubMed ID: 12036919
    [Abstract] [Full Text] [Related]

  • 30. Role of tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus infection in mice.
    Ishikawa E, Nakazawa M, Yoshinari M, Minami M.
    J Virol; 2005 Jun 01; 79(12):7658-63. PubMed ID: 15919918
    [Abstract] [Full Text] [Related]

  • 31. Autoamplification of apoptosis following ligation of CD95-L, TRAIL and TNF-alpha.
    Herr I, Posovszky C, Di Marzio LD, Cifone MG, Boehler T, Debatin KM.
    Oncogene; 2000 Aug 31; 19(37):4255-62. PubMed ID: 10980599
    [Abstract] [Full Text] [Related]

  • 32. Expression of TNF-related apoptosis-inducing ligand in human hepatocellular carcinoma.
    Shiraki K, Yamanaka T, Inoue H, Kawakita T, Enokimura N, Okano H, Sugimoto K, Murata K, Nakano T.
    Int J Oncol; 2005 May 31; 26(5):1273-81. PubMed ID: 15809718
    [Abstract] [Full Text] [Related]

  • 33. A dual role for both CD40-ligand and TNF-alpha in controlling human B cell death.
    Lens SM, Tesselaar K, den Drijver BF, van Oers MH, van Lier RA.
    J Immunol; 1996 Jan 15; 156(2):507-14. PubMed ID: 8543800
    [Abstract] [Full Text] [Related]

  • 34. Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms.
    Lewinsohn DM, Bement TT, Xu J, Lynch DH, Grabstein KH, Reed SG, Alderson MR.
    J Immunol; 1998 Mar 01; 160(5):2374-9. PubMed ID: 9498779
    [Abstract] [Full Text] [Related]

  • 35. Suppression of human B cell responsiveness by CD4+ T cells does not involve CD95-CD95 ligand interactions.
    Hirohata S.
    Cell Immunol; 1997 Nov 01; 181(2):182-91. PubMed ID: 9398405
    [Abstract] [Full Text] [Related]

  • 36. Lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): a new receptor protecting lymphocytes from the death ligand TRAIL.
    Mongkolsapaya J, Cowper AE, Xu XN, Morris G, McMichael AJ, Bell JI, Screaton GR.
    J Immunol; 1998 Jan 01; 160(1):3-6. PubMed ID: 9551946
    [Abstract] [Full Text] [Related]

  • 37. Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL.
    Ando K, Hiroishi K, Kaneko T, Moriyama T, Muto Y, Kayagaki N, Yagita H, Okumura K, Imawari M.
    J Immunol; 1997 Jun 01; 158(11):5283-91. PubMed ID: 9164947
    [Abstract] [Full Text] [Related]

  • 38. Fas/Fas ligand interactions are involved in ultraviolet-B-induced human lymphocyte apoptosis.
    Caricchio R, Reap EA, Cohen PL.
    J Immunol; 1998 Jul 01; 161(1):241-51. PubMed ID: 9647230
    [Abstract] [Full Text] [Related]

  • 39. Fas (CD95, APO-1) antigen expression and function in murine mast cells.
    Hartmann K, Wagelie-Steffen AL, von Stebut E, Metcalfe DD.
    J Immunol; 1997 Oct 15; 159(8):4006-14. PubMed ID: 9378990
    [Abstract] [Full Text] [Related]

  • 40. Cutting edge: CD4+ T cells kill CD8+ T cells via Fas/Fas ligand-mediated apoptosis.
    Piazza C, Gilardini Montani MS, Moretti S, Cundari E, Piccolella E.
    J Immunol; 1997 Feb 15; 158(4):1503-6. PubMed ID: 9029083
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.